Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545765 · ClinicalTrials.gov registry record · Phase 4
Anesthetic Effect Duration Assessment
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT01545765 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 30 participants.
The verdict
NCT01545765, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the duration of anesthetic effect produced , Lidocaine7% + Tetracaine 7% cream when applied with 2 different application times on the face and thigh.
Interventions
- DRUG Lidocaine 7% + Tetracaine 7% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01545765
The ClinicalTrials.gov registry entry for NCT01545765 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine 7% + Tetracaine 7% cream is the first listed.
NCT01545765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01545765 about?
NCT01545765 is a clinical study titled "Anesthetic Effect Duration Assessment". The purpose of this study is to evaluate the duration of anesthetic effect produced , Lidocaine7% + Tetracaine 7% cream when applied with 2 different application times on the face and thigh.
What is the current status of trial NCT01545765?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2012-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01545765?
The interventions under investigation include: Lidocaine 7% + Tetracaine 7% cream (DRUG).
Who is sponsoring clinical trial NCT01545765?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.